Seeking Alpha

ChicagoVol

ChicagoVol
Send Message
View as an RSS Feed
View ChicagoVol's Comments BY TICKER:
Latest  |  Highest rated
  • Over 1M affected as extended unemployment benefits expire [View news story]
    It is excuses like the inability to get a haircut and obtaining a job is why most are unable to find a job within 99 weeks. Stop making excuses because life has not turned out the way it did in your fairytale.
    Dec 30 01:57 AM | 2 Likes Like |Link to Comment
  • Over 1M people set to lose unemployment benefits [View news story]
    You find a job with whatever the pay and continue to look for that ideal job instead of only looking for that ideal job while wasting taxpayers money. It's always the abusers that hurt things for everyone, but 99 weeks is just ridiculous. That's almost 2 years of a free ride.
    Dec 27 10:03 AM | 7 Likes Like |Link to Comment
  • Obamacare "fix" puts insurers in a tough spot [View news story]
    Agreed. Now they just a reason to continue to increase mine and everyone else's premiums.
    Nov 14 10:28 PM | Likes Like |Link to Comment
  • Obamacare enrollment miles away from goals [View news story]
    Didn't know privacy was a concern by the administration.
    Nov 12 09:35 AM | 2 Likes Like |Link to Comment
  • Why I Don't Invest In Companies That Layoff Employees [View article]
    You can add Pfizer to the list as well.
    Oct 23 01:14 AM | Likes Like |Link to Comment
  • Herbalife: An Ethical Short [View article]
    The weight loss saved her life. The insulin was only controlling her blood sugar and causing her to gain more weight which would have cause blood pressure to go up and the need for more insulin.
    Sep 30 09:08 AM | 8 Likes Like |Link to Comment
  • Apple's FaceTime workaround costs $2.4M/month, 500k complaints [View news story]
    Apple just needs to buy them out and be done with it.
    Aug 30 09:49 PM | 1 Like Like |Link to Comment
  • Affymax Likely Worthless: Omontys Kills At Least 9x More People Than Epogen [View article]
    That's not what I was saying. That would be absolutely crazy to leave something unsafe on the market.
    Aug 30 12:40 AM | Likes Like |Link to Comment
  • Affymax Likely Worthless: Omontys Kills At Least 9x More People Than Epogen [View article]
    It sounds like someone is a recent graduate from the Ackman Institute of Intimidation for Shorting Stocks.

    According to the FDA, a NDA does not depend on how well a medicine does compared to others in its class of colony stimulating factors or in any other class of medications.

    This is taken from FDA.gov. The goals of the NDA are to provide enough information to permit FDA reviewer to reach the following key decisions:
    Whether the drug is safe and effective in its proposed use(s), and whether the benefits of the drug outweigh the risks.
    Whether the drug's proposed labeling (package insert) is appropriate, and what it should contain.
    Whether the methods used in manufacturing the drug and the controls used to maintain the drug's quality are adequate to preserve the drug's identity, strength, quality, and purity.

    Just because a side effect shows up more does not make it less same. In the class of CSF, all of the medications listed in Epocrates have similar side effects but some might be more pronounced in some medications than others. Just like myalgias and rhabdomyolysis are more common with Crestor when compared with Zocor. It does not mean Crestor is not safe and should be removed from the market. It just means that it is stronger, therefore, side effects may be more common with it.

    Also, Fresenius is currently in several legal battles over practices in some of their clinics and this gives the speculation that there is some sort of human error by the clinics.

    I have a small position in this stock to ride for speculation and possibly adding some later or riding it down if bad news is in the future. I did my research on both sides of the argument and just did not pick one and run with it to persuade others to follow a partially uneducated opinion on the stock.
    Aug 29 12:13 AM | 2 Likes Like |Link to Comment
  • Ackman talks Herbalife in Q2 letter, says chances of regulatory action up materially [View news story]
    S&P 500 is up 16% YTD.
    Dow is up 14% YTD.
    Nasdaq is up 20% YTD.
    HLF is up 92.74% YTD.
    Aug 22 11:19 PM | 1 Like Like |Link to Comment
  • Ackman talks Herbalife in Q2 letter, says chances of regulatory action up materially [View news story]
    And what would it be if we remove the gains from General Growth Properties?
    Aug 22 12:00 AM | Likes Like |Link to Comment
  • Green Mountain Coffee Roasters lower after Barron's warning [View news story]
    http://seekingalpha.co...
    Aug 5 08:36 AM | 1 Like Like |Link to Comment
  • Bill Ackman's Pershing Square fires it latest salvo at Herbalife (HLF -1.05%), comparing the nutrition company to Fortune Hi-Tech Marketing, which was charged in January with operating an illegal pyramid scheme and making false earnings claims. [View news story]
    Same argument. Just a different way to say it to help his cause.
    Mar 14 01:43 PM | Likes Like |Link to Comment
  • Reopened for trade, Clearwire (CLWR) falls 8.3% to $3.09 premarket after its board approved the sale of the company to Sprint (S) for $2.97/share. Sprint gains 2.7%[View news story]
    7 cents. Thank God I held on for 7 cents.
    Dec 17 08:36 AM | Likes Like |Link to Comment
  • Sprint (S) offers to buy the portion of Clearwire (CLWR) it doesn't already own for $2.90 a share, according to a SEC filing. The company proposes to provide interim financing of up to $800M. CLWR +1.8% premarket. [View news story]
    I wondered why I woke up with a red hand print on the side of my face. I guess it was from S slapping me in the face.
    Dec 13 08:52 AM | Likes Like |Link to Comment
COMMENTS STATS
27 Comments
31 Likes